Manufacture and distribution of GMP-certified, THC-containing medical cannabis for pharmacies, hospitals and pharmaceutical companies.
Swisscann tec AG
Zurich (Headquarters) · Glattfelden (Production)New on Amplifa
About swisscann tec
Swisscann tec AG is a Swiss medical cannabis company headquartered in Technopark Zurich with a production facility in Glattfelden. Founded in 2017, the company produces THC-containing medical cannabis flowers and active pharmaceutical ingredients (APIs) in accordance with EU-GMP. Cultivation takes place in a closed cleanroom environment following GACP guidelines, with hydroponic and aeroponic systems, computer-controlled climate management and automated irrigation. Processing includes drying, further processing, packaging and storage in accordance with GMP. The production facility was commissioned in 2022; EU-GMP certification by Swissmedic followed on 14 December 2023. Customers are pharmacies, hospitals and pharmaceutical companies in Switzerland and the EU; since 2024 there has been an exclusive partnership with alephSana for the joint Swiss Essence Line in Germany.
- Site
- Zürich
- Processes
- Cultivation of medical cannabis (THC-containing) according to GACP guidelines, Hydroponic cultivation, Aeroponic cultivation, Manufacture of Active Pharmaceutical Ingredients (APIs) under EU-GMP, Drying of cannabis flowers (GMP-certified), Processing/further processing of medical cannabis according to GMP, Packaging according to pharmaceutical standards (GMP), Storage according to GMP standards
- Materials
- Medical Cannabis (THC-containing, cannabinoids THC, CBD, CBG, CBN), Medical Cannabis (THC-containing), Active Pharmaceutical Ingredients (APIs), Cannabinoids (CBD, CBG, CBN), Aeroponic and hydroponic cultivation systems, Genetics from Tissue Culture Labs
- Certificates
- EU-GMP (Good Manufacturing Practice), GDP (Good Distribution Practice) Authorisation for Wholesale/Import/Export, Cultivation Licence for Medical Cannabis (THC), Narcotics / Medicinal Product Manufacturing Licence, EU-GMP (Swissmedic), GDP Authorisation (Swissmedic), Narcotics/Medicinal Product Manufacturing Licence
- Founded
- 2017
- Industries
- Medical Cannabis, Pharmaceutical Industry, Pharmacies, Hospitals/Healthcare
- 01
Cultivation according to GACP (hydroponic/aeroponic)
- 02
Harvest
- 03
Drying (GMP)
- 04
Further processing (GMP)
- 05
Testing
- 06
Packaging (GMP)
- 07
Storage (GMP)
- 08
Distribution according to GDP (wholesale, import/export)
Cultivation Systems and Processing
Medical Cannabis (THC-containing)
THC-containing cannabis flowers as starting material for medicinal products and APIs.
Active Pharmaceutical Ingredients (APIs)
Active ingredients produced under EU-GMP for pharmacies, hospitals and pharmaceutical companies.
Cannabinoids (CBD, CBG, CBN)
Pharmacologically relevant cannabinoids with standardised composition.
Aeroponic and hydroponic cultivation systems
Genetics-dependent use of both systems to optimise growth results and active ingredient profile.
Genetics from Tissue Culture Labs
Virus- and disease-free plant basis from a genetics bank comprising more than 200 varieties.
Locations
Zurich
CHHeadquarters
Glattfelden
CHProduction (GMP facility, cleanroom environment)
- Materials
- Medical Cannabis (THC-containing)
- Aeroponic cultivation system
- Hydroponic cultivation system
- Automated irrigation system
- Computer-controlled climate control (temperature, humidity, nutrients, lighting)
- GMP-certified cleanroom production facility (drying, processing, packaging, storage)
Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| Cultivation of medical cannabis (THC-containing) according to GACP guidelinesPlastics | – | – | – | – | Cannabis (THC-containing medical varieties) |
| Hydroponic cultivationPlastics | – | – | – | – | Cannabis (THC-containing medical varieties) |
| Aeroponic cultivationPlastics | – | – | – | – | Cannabis (THC-containing medical varieties) |
| Manufacture of Active Pharmaceutical Ingredients (APIs) under EU-GMPPlastics | – | – | – | – | Cannabis flowers (medical cannabis) |
| Drying of cannabis flowers (GMP-certified)Plastics | – | – | – | – | Cannabis flowers |
| Processing/further processing of medical cannabis according to GMPPlastics | – | – | – | – | Cannabis flowers |
| Packaging according to pharmaceutical standards (GMP)Assembly | – | – | – | – | Cannabis flowers / cannabis products |
| Storage according to GMP standardsAssembly | – | – | – | – | Cannabis products |
| Wholesale / distribution according to GDP (import/export)Assembly | – | – | – | – | GMP-certified medical cannabis products |
5 Anlagen & Maschinen
| Machine | Manufacturer / model | Quantity | Working area | Year built | Site |
|---|---|---|---|---|---|
| Aeroponic cultivation system | – | – | – | – | Glattfelden |
| Hydroponic cultivation system | – | – | – | – | Glattfelden |
| Automated irrigation system | – | – | – | – | Glattfelden |
| Computer-controlled climate control (temperature, humidity, nutrients, lighting) | – | – | – | – | Glattfelden |
| Cleanroom production facility (GMP-certified, in operation since 2022) | – | – | – | 2022 | Glattfelden (Nidermattstrasse 11, CH-8192) |
Additional services
Reference customers
Quality and Authorisations
Production takes place in a GMP-certified cleanroom environment and is regularly inspected and supervised by Swissmedic. A quality management manager, a technically responsible person for GMP and a responsible person for narcotics have been designated.
| Evidence | Glattfelden |
|---|---|
| EU-GMP (Swissmedic) | |
| GDP Authorisation (Swissmedic) | |
| Cultivation Licence for Medical Cannabis (THC) | |
| Narcotics/Medicinal Product Manufacturing Licence |
Company History
- 2017
Foundation of swisscann in the early days of cannabis legalisation.
- 2022
Commissioning of the GMP production facility in Glattfelden; Swiss legislative change as of 1 August 2022 permits the cultivation, manufacture and export of medical cannabis
- 2023
Receipt of EU-GMP certification by Swissmedic on 14 December 2023.
- 2024
First cultivation cycle of medical cannabis flowers with high THC content (June 2024); CEO panel discussion at Cannabis Business Expo Dortmund (September 2024)
- 2024
Exclusive partnership with alephSana for the joint Swiss Essence Line in Germany (20 December 2024)